AXGN · AxoGen, Inc.
$38.02
-0.10% last session
End-of-day data · close of 2026-10-26
Market cap
$2B
Enterprise value
$2B
Trailing P/E
—
Forward P/E
52.4
Dividend yield
0.0%
Beta
1.17
Avg volume
1M
Employees
1K
Daily Change %
-0.10%
5 Days Change
3.65%
10 Days Change
9.82%
30 Days Change
-12.38%
60 Days Change
-26.13%
Month to Day Change
-4.76%
Year to Day Change
16.16%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — AXGN
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-23
Latest call per bank · past 12 months
Barclays
Overweight$50.00
+31.5% vs priceBank of America
Buy$52.00
+36.8% vs priceWells Fargo
Overweight$48.00
+26.2% vs priceJefferies
Buy$36.00
-5.3% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-23 | Barclays | Maintains | Overweight | $55.00 → $50.00 |
| 2026-10-12 | Bank of America | Initiates | Buy | $0.00 → $52.00 |
| 2026-10-07 | Barclays | Initiates | Overweight | $0.00 → $55.00 |
| 2026-10-01 | Truist Securities | Maintains | Buy | $60.00 → $53.00 |
| 2026-09-25 | Raymond James | Maintains | Outperform | $48.00 → $53.00 |
| 2026-08-26 | Truist Securities | Initiates | Buy | $0.00 → $60.00 |
| 2026-07-30 | Canaccord Genuity | Maintains | Buy | $50.00 → $55.00 |
| 2026-07-30 | Citizens | Maintains | Market Outperform | $50.00 → $55.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-26
- neutral: RSI (14): RSI is 46 — neutral momentum, neither overbought nor oversold.
- bearish: Price vs 50-day MA: Trading 11.7% below the 50-day MA ($43.04).
- bearish: Price vs 200-day MA: Trading 3.2% below the 200-day MA ($39.28).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bullish: MACD (12,26,9): MACD histogram is positive (+0.52) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($17.77) and high ($51.73).
AXGN Price Chart
Loading chart for AXGN…
Fundamentals
About AxoGen, Inc.
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.
More in Medical Devices
ABT
Abbott Laboratories
$181B -14.2% YTD
MDT
Medtronic plc.
$121B 1.2% YTD
SYK
Stryker Corporation
$117B -12.2% YTD
BSX
Boston Scientific Corporation
$66B -52.2% YTD
EW
Edwards Lifesciences Corporatio
$52B 6.2% YTD
GEHC
GE HealthCare Technologies Inc.
$33B -12.1% YTD
DXCM
DexCom, Inc.
$30B 18.4% YTD
PHG
Koninklijke Philips N.V. NY Reg
$26B 1.9% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.